Location History:
- Mulgrave Victoria, AU (2003)
- Mulgrave, AU (2007 - 2008)
- Pakenham, AU (2011)
Company Filing History:
Years Active: 2003-2011
Title: Robert Alexander Irving: Innovator in Immunology
Introduction
Robert Alexander Irving, an accomplished inventor based in Mulgrave, Australia, has made significant contributions to the field of immunology. With a total of four patents to his name, Irving's work focuses on the development of binding moieties derived from fish immunoglobulin domains, showcasing his innovative spirit and dedication to scientific advancement.
Latest Patents
Irving's latest patents highlight his expertise in creating novel immunoglobulin new antigen receptors (IgNARs). One of his recent inventions, "Binding moieties based on shark ignar domains," relates to modified IgNAR variable domains and the structural features derived from these domains. This innovation has practical applications in the development of targeted therapies. Another notable patent, "V-like domain binding molecules and polynucleotides encoding therefor," explores binding moieties comprised of monomeric V-like domains. This invention improves the solubility of modified V-like domains, enhancing their practical use in various medical applications.
Career Highlights
Throughout his career, Robert Alexander Irving has held pivotal roles in various companies, including Diatech Pty. Ltd. and Adalta Pty Ltd. His work in these organizations has furthered research and development in the field of biomedicine, reflecting his commitment to harnessing scientific breakthroughs for practical use.
Collaborations
Irving has collaborated with several notable professionals in his field, including Peter John Hudson and Maria Galanis. These partnerships have not only enriched his research but have also contributed to advancements in immunological therapies and technologies.
Conclusion
Robert Alexander Irving exemplifies the innovative spirit of modern inventors through his groundbreaking work in immunology. With multiple patents that push the boundaries of scientific inquiry, his contributions are poised to make a lasting impact. As he continues to advance his research, the future of immunological therapies looks promising, thanks to inventors like him.